A study by Guldur et al. [48] showed 66.7% of LCC samples, 53.4% of SCC and 42% of adenocarcinoma with positive beta-catenin staining, while all of their SCLC samples showed reduced beta-catenin staining. This evidence concerns the gene CTNNB1 and leukoencephalopathy with calcifications and cysts.